Related Experiment Video
Updated: Jun 19, 2026

05:05
Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
Metastases development following local tumour treatment
A Jurin1, T Jukić, S Ivanković
1County Hospital Cakovec, Cakovec, Croatia. jurin@irb.hr
Folia Biologica
|October 30, 2009
Summary
Local tumor treatment reduced lung metastases in mice. However, adding tumor mass increased metastases, suggesting immune responses and nitric oxide release play key roles in tumor spread after therapy.
Area of Science:
- Oncology
- Immunology
- Cancer Metastasis Research
Background:
- Local tumor treatment can influence distant metastases.
- Understanding the mechanisms of metastasis post-treatment is crucial for effective cancer therapy.
- The role of the host immune response in tumor metastasis requires further investigation.
Purpose of the Study:
- To investigate the impact of local tumor treatment on lung metastases.
- To explore the influence of tumor burden on metastasis development after treatment.
- To elucidate potential mechanisms, such as immune reactions and nitric oxide, involved in tumor metastasis.
Main Methods:
- Utilized a transplantable methylcholanthrene-induced fibrosarcoma (CMC4) model in mice.
- Administered local treatments including surgery and/or irradiation to primary tumors.
- Introduced irradiated, non-dividing tumor cells to simulate increased tumor burden in treated mice.
Main Results:
- Reduced primary tumor mass led to significantly fewer and smaller lung metastases.
- Increased tumor burden (via irradiated cell injection) significantly elevated lung metastases.
- Findings suggest a role for host immune reactions in modulating metastasis.
Conclusions:
- Local tumor treatment can reduce lung metastasis, but the host's immune response is a critical factor.
- Nitric oxide release from tumor mass may inhibit tumor cell survival and metastasis by affecting angiogenesis and immunity.
- Complex interactions between tumor, treatment, and host immunity govern metastasis outcomes.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

